Single-Cell RNA Sequencing Identifies MMP11(+) Cancer-Associated Fibroblasts as Drivers of Angiogenesis and Bladder Cancer Progression.
Xu W, Liang T, Fang H, Fu L, Deng D, Tan X, Liu L, Tang D, Zheng H, Ding Q, Hou X, Feng D, Tao T, Wu S.
Adv Sci (Weinh). 2025 Aug;12(32):e02774. doi: 10.1002/advs.202502774. Epub 2025 Jun 24.
The expanding repertoire of targets for immune checkpoint inhibition in bladder cancer: What lies beneath the tip of the iceberg, PD-L1.
Sankin A, Narasimhulu D, John P, Gartrell B, Schoenberg M, Zang X.
Urol Oncol. 2018 Oct;36(10):459-468. doi: 10.1016/j.urolonc.2017.04.007. Epub 2017 May 8.
The use of the marker tumor concept in Ta, T1 bladder cancer: is it justified?
van der Meijden AP.
Urol Oncol. 2002 Jan-Feb;7(1):31-3. doi: 10.1016/s1078-1439(01)00156-9.
Lymphoepithelioma-like carcinoma of the urinary bladder: a case report and review of the literature.
Yoshino T, Ohara S, Moriyama H.
BMC Res Notes. 2014 Nov 4;7:779. doi: 10.1186/1756-0500-7-779.
Bladder cancer.
van der Meijden AP.
BMJ. 1998 Nov 14;317(7169):1366-9. doi: 10.1136/bmj.317.7169.1366.
Efficacy of Open-Ended Urinary Catheters in Preventing Catheter-Related Bladder Discomfort: A Randomized Controlled Trial.
Kobatake K, Goto K, Hatayama T, Naito M, Takemoto K, Miyamoto S, Sekino Y, Kitano H, Goriki A, Hieda K, Hinata N.
Int J Urol. 2025 Dec;32(12):1819-1826. doi: 10.1111/iju.70225. Epub 2025 Sep 14.
SIGMAR1 screened by a GPCR-related classifier regulates endoplasmic reticulum stress in bladder cancer.
Zhuang J, Wang Y, Wu X, Peng Z, Huang Z, Zhao C, Shen B.
J Transl Med. 2025 Apr 10;23(1):417. doi: 10.1186/s12967-025-06393-7.
[Trans-urethral whole layer core biopsy of invasive bladder tumor].
Hoshi S, Orikasa S, Yoshikawa K, Saitoh S, Ohyama C, Satoh M, Kawamura S, Suzuki K.
Nihon Hinyokika Gakkai Zasshi. 1994 May;85(5):715-21. doi: 10.5980/jpnjurol1989.85.715.
Whole bladder photodynamic therapy: critical review of present-day technology and rationale for development of intravesical laser catheter and monitoring system.
Nseyo UO, Lundahl SL, Merrill DC.
Urology. 1990 Nov;36(5):398-402. doi: 10.1016/s0090-4295(90)80283-s.
Analysis of risk factors for cancer-specific survival in neoadjuvant chemotherapy nonresponsive disease of muscle-invasive bladder cancer: A multicentre study from the Turkish Urooncology Association Bladder Tumor study group.
Teke K, Yılmaz H, Baltacı S, Akgül M, Şahin B, Türkeri L, Bozkurt O, Yücetaş U, Aslan G, Bolat D, İzol V, Özkan TA, Eskiçorapçi S; Turkish Urooncology Association Bladder Tumor study group.
Urol Oncol. 2025 Jan;43(1):61.e11-61.e18. doi: 10.1016/j.urolonc.2024.09.006. Epub 2024 Sep 30.
